Priyanka C. Iyer, Director of Oncologic Endocrinology Fellowship Program at UT MD Anderson, shared on LinkedIn:
“Honored to receive the Winn Trailblazer award this year from the Bristol Myers Squibb Foundation in recognition for GRASSROOT (NCT06507878), a master observational trial looking at real world evidence in the management of Anaplastic thyroid cancer (ATC).
It all started one fine day in the summer of 2023 when I was in my mentors office discussing clinical trial ideas to launch my career as an early career physician researcher. Our meeting was interrupted when she received an email from the county hospital seeking guidance regarding management of a patient with ATC who didn’t have insurance to come to MD Anderson. This was an incredibly heartbreaking predicament as this patient was literally across the street but could not access our expertise directly.
My mentor responded to the email with steps on how to approach this patients care and added me on this. Eventually with the help of social work office at MD Anderson, the patient was able to see me and received care in my clinic.
However, that made me realize that while this patient got lucky to have an insurance change, there are so many patients with ATC out there who cannot access our expertise or clinical trials due to insurance related reasons.
Made me wonder if they can’t come to us, how about we go to them? How could we take our clinical trials to the community, expand the outreach of our expertise.
This urge to do better led us to design the trial GRASSROOT– which stands for ‘Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment’.
Today, through GRASSROOT we have successfully expanded the outreach of our ATC expertise to 4 sites –
- 2 domestic sites including the county hospital
- 2 international sites and have enrolled 128 ATC patients since Dec 2024.
We continue to enroll and are actively seeking additional sites to expand the spread of this prospective clinical trial.
I would like to thank my mentor Maria E. Cabanillas for her guidance and sponsorship for recognizing my efforts in making expertise accessible to ATC patients globally. She is truly an inspiration and an outstanding role model for clinicians like me.
I am also incredibly grateful to the Winn Awards and BMS foundation for recognizing the novelty of this approach and funding my research time as I worked on planting the roots for this project.
Dr. Rob Winn’s vision in bringing academia and industry to a common ground, has led to this very unique award mechanism which sponsors early career clinician scientists in developing trials with community outreach and engagement. Thank you for all you do!
The work has only begun, and we have a long way to go before we spread ‘grassroot‘s around the globe to eliminate this deadly disease.”

You can also read:
- Winn Awards Find New Home at Fox Chase Cancer Center to Expand Clinical Trial Opportunities
- The Rising Burden of Thyroid Cancer in Adolescents: Overdiagnosis, a Genuine Increase – or Both?
